Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

19.63p
   
  • Change Today:
    -0.13p
  • 52 Week High: 172.00
  • 52 Week Low: 19.50
  • Currency: UK Pounds
  • Shares Issued: 182.34m
  • Volume: 109,994
  • Market Cap: £35.78m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

Key Personnel

CEO: Craig Jonathan Gulliford
CFO: Richard John Rees
Chief Technology Officer: Christopher Paul Hancock
Executive Director: David Gerard Woods
Independent Non-Executive Director: Ivonne Cantu
Independent Non-Executive Director: John Bradshaw
Non-Executive Chairman: Charles Spicer
Non-Executive Dir:

Contact Details

Address: Creo House, Unit 2 Beaufort Park, Beaufort Park Way, Chepstow, Wales, United Kingdom , NP16 5UH
Phone: +44 (0) 1291 606005
Website: http://creomedical.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BZ1BLL44

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 19.63p
Change Today -0.13p
% Change -0.63 %
52 Week High 172.00
52 Week Low 19.50
Volume 109,994
Shares Issued 182.34m
Market Cap £35.78m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.19% above the market average72.19% above the market average72.19% above the market average72.19% above the market average72.19% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average
Price Trend
98.71% below the market average98.71% below the market average98.71% below the market average98.71% below the market average98.71% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
48.84% above the market average48.84% above the market average48.84% above the market average48.84% above the market average48.84% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 03-Feb-2023

Time Volume / Share Price
16:35 55 @ 19.50p
16:13 25 @ 19.57p
16:05 100 @ 19.50p
15:25 13 @ 19.57p
15:25 51 @ 19.57p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page